ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

AXA S.A.'s Holding History (CIK: 0000898427)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 2,650,000 Value ($000) $3,452 Avg Close — Range —
Q1 2025
Shares 2,650,000 Value ($000) $3,057 Avg Close — Range —
Q4 2024
Shares 3,250,000 Value ($000) $3,471 Avg Close — Range —
Q3 2024
Shares 3,500,000 Value ($000) $4,100 Avg Close — Range —
Q2 2024
Shares 3,500,000 Value ($000) $3,769 Avg Close — Range —
Q1 2024
Shares 7,700,000 Value ($000) $7,242 Avg Close — Range —
Q4 2023
Shares 8,250,000 Value ($000) $8,247 Avg Close — Range —
Q3 2023
Shares 7,950,000 Value ($000) $7,388 Avg Close — Range —